The DOI matches its Crossref record; 765 of the 770 references it cites were found in a registry or an index.
The epigenetics of aging and neurodegeneration
Open accessAbstract
Epigenetics is a quickly growing field encompassing mechanisms regulating gene expression that do not involve changes in the genotype. Epigenetics is of increasing relevance to neuroscience, with epigenetic mechanisms being implicated in brain development and neuronal differentiation, as well as in more dynamic processes related to cognition. Epigenetic regulation covers multiple levels of gene expression; from direct modifications of the DNA and histone tails, regulating the level of transcription, to interactions with messenger RNAs, regulating the level of translation. Importantly, epigenetic dysregulation currently garners much attention as a pivotal player in aging and age-related neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, where it may mediate interactions between genetic and environmental risk factors, or directly interact with disease-specific pathological factors. We review current knowledge about the major epigenetic mechanisms, including DNA methylation and DNA demethylation, chromatin remodeling and non-coding RNAs, as well as the involvement of these mechanisms in normal aging and in the pathophysiology of the most common neurodegenerative diseases. Additionally, we examine the current state of epigenetics-based therapeutic strategies for these diseases, which either aim to restore the epigenetic homeostasis or skew it to a favorable direction to counter disease pathology. Finally, methodological challenges of epigenetic investigations and future perspectives are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, the cellular heterogeneity of the AD brain presents significant analytical hurdles. Advanced computational deconvolution techniques or experimental methods such as fluorescence-activated cell sorting (FACS) are often required to resolve distinct cell populations, including neurons, astrocytes, and microglia127,157.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 601–765 of 765
Choudhuri, S. (2011) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2011.559695 · Cited by 91
Wang, C. M., Tsai, S. N., Yew, T. W. D., Kwan, Y. W., & Ngai, S. M. (2009) · Biogerontology · doi:10.1007/s10522-009-9231-5 · Cited by 91
Chouliaras, L., L.A. van den Hove, D., Kenis, G., Keitel, S., R. Hof, P., van Os, J., W.M. Steinbusch, H., Schmitz, C., & P.F. Rutten, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512800618035 · Cited by 91
Self-citationAge-related difference of site-specific histone modifications in rat liver
Kawakami, K., Nakamura, A., Ishigami, A., Goto, S., & Takahashi, R. (2008) · Biogerontology · doi:10.1007/s10522-008-9176-0 · Cited by 91
Epigenetic Mechanisms of Neurodegeneration in Huntington's Disease
Lee, J.-H., Hwang, Y. J., Kim, K. Y., Kowall, N. W., & Ryu, H. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0206-5 · Cited by 90
HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila
Xiong, Y., Zhao, K., Wu, J., Xu, Z., Jin, S., & Zhang, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207586110 · Cited by 90
Caloric restriction attenuates age-related changes of DNA methyltransferase 3a in mouse hippocampus
Chouliaras, L., van den Hove, D. L. A., Kenis, G., Dela Cruz, J., Lemmens, M. A. M., van Os, J., Steinbusch, H. W. M., Schmitz, C., & Rutten, B. P. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.11.016 · Cited by 89 · cited 15×
“Furthermore, there is another DNMT, DNMT3-like (DNMT3L), which exhibits no enzymatic activity, but detects unmethylated lysine 4 of histone H3 tails (H3K4) and recruits or activates DNMT3a (Ooi et al., 2007).”
BackgroundResultInfluentialSelf-citationSodium phenylbutyrate in Huntington's disease: A dose‐finding study
Hogarth, P., Lovrečić, L., & Krainc, D. (2007) · Movement Disorders · doi:10.1002/mds.21632 · Cited by 89
Current status and future prospects for epigenetic psychopharmacology
Boks, M. P., de Jong, N. M., Kas, M. J. H., Vinkers, C. H., Fernandes, C., Kahn, R. S., Mill, J., & Ophoff, R. A. (2012) · Epigenetics · doi:10.4161/epi.7.1.18688 · Cited by 89
Extensive relationship between antisense transcription and alternative splicing in the human genomePreprint
Morrissy, A. S., Griffith, M., & Marra, M. A. (2011) · Genome Research · doi:10.1101/gr.113431.110 · Cited by 88
The nucleotide sequence of nuclear 4.8S RNA of mouse cells
Harada, F., Kato, N., & Nishimura, S. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91620-4 · Cited by 88
Epigenome-Wide Association Study for Parkinson’s Disease
Moore, K., McKnight, A. J., Craig, D., & O’Neill, F. A. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8332-8 · Cited by 87
Polyglutamine diseases: a transcription disorder?
Okazawa, H. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3013-z · Cited by 87
Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?
Hoyer, S., Lee, S. K., Löffler, T., & Schliebs, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06932.x · Cited by 87
Dasgupta, S., Zhou, Y., Jana, M., Banik, N. L., & Pahan, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3874 · Cited by 87
Sommer, M., Poliak, N., Upadhyay, S. K., Ratovitski, E. A., Nelkin, B. D., Donehower, L. A., & Sidransky, D. (2006) · Cell Cycle · doi:10.4161/cc.5.17.3194 · Cited by 86
Silva, P. N., Gigek, C. O., Leal, M. F., Bertolucci, P. H. F., de Lábio, R. W., Payão, S. L. M., & Smith, M. D. A. C. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13207 · Cited by 86
Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells
Suuronen, T., Nuutinen, T., Ryhänen, T., Kaarniranta, K., & Salminen, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.135 · Cited by 85
Epigenetic regulation of BACE1 in Alzheimer’s disease patients and in transgenic mice
Marques, S., Lemos, R., Ferreiro, E. B., Martins, M., de Mendonça, A., Santana, I. J., Outeiro, T. F., & Pereira, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.029 · Cited by 84
APOBEC3 proteins: major players in intracellular defence against LINE-1-mediated retrotransposition
Schumann, G. G. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350637 · Cited by 83
Effect of valproic acid on mitochondrial epigenetics
Chen, H., Dzitoyeva, S., & Manev, H. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.06.019 · Cited by 83
Pirooznia, S. K., Sarthi, J. B., Johnson, A. A., Toth, M. S., Chiu, K., Koduri, S., & Elefant, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041776 · Cited by 83
Rossi, L. E., Avila, D. E., Spallanzani, R. G., Ziblat, A., Fuertes, M. B., Lapyckyj, L., Croci, D. O., Rabinovich, G. A., Domaica, C. I., & Zwirner, N. W. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0711339 · Cited by 83
Epigenetic programming of neurodegenerative diseases by an adverse environment
Babenko, O., Kovalchuk, I., & Metz, G. A. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.038 · Cited by 80
Chandola, U., Das, R., & Panda, B. (2014) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu039 · Cited by 80
Parra, M., Mahmoudi, T., & Verdin, E. M. (2007) · Genes & Development · doi:10.1101/gad.1513107 · Cited by 80
Hoyaux, D., Decaestecker, C., Heizmann, C. W., Vogl, T. J., Schäfer, B. W., Salmon, I. J., Robert Kiss, A., & Pochet, R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02393-3 · Cited by 79
Lunnon, K., & Mill, J. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32201 · Cited by 78
Prevention of age-related changes in hippocampal levels of 5-methylcytidine by caloric restriction
Chouliaras, L., van den Hove, D. L. A., Kenis, G., Keitel, S., Hof, P. R., van Os, J., Steinbusch, H. W. M., Schmitz, C., & Rutten, B. P. F. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.06.003 · Cited by 78
Self-citationBrown, S. E., Weaver, I. C. G., Meaney, M. J., & Moshe Szyf, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.028 · Cited by 77
Histone acetylation during aging of human cells in culture
Ryan, J. M., & Cristofalo, V. J. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90668-7 · Cited by 77
Johnson, A. A., Sarthi, J. B., Pirooznia, S. K., Reube, W., & Elefant, F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3739-12.2013 · Cited by 76
Epigenetics, a key for unlocking complex CNS disorders? Therapeutic implications
Szyf, M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.009 · Cited by 76
Epigenetics in the Human Brain
Houston, I. B., Peter, C. J., Mitchell, A., Straubhaar, J., Rogaev, E. I., & Akbarian, S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.78 · Cited by 75
Fontán‐Lozano, Á., Suárez‐Pereira, I., Horrillo, A., Martín, Y. D. P., Hmadcha, A., & Carrión, Á. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3010-10.2010 · Cited by 74
Coppedè, F., Tannorella, P., Pezzini, I., Migheli, F., Ricci, G., Ienco, E. C., Piaceri, I., Polini, A., Nacmias, B., Monzani, F., et al. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4368 · Cited by 74
MicroRNA and proteome expression profiling in early‐symptomatic α‐synuclein(A30P)‐transgenic mice
Gillardon, F., Mack, M., Rist, W., Schnack, C., Lenter, M., Hildebrandt, T., & Hengerer, B. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780025 · Cited by 73
Colchicines-induced neurotoxicity as an animal model of sporadic dementia of Alzheimer's type.
Kumar, A., Seghal, N., Naidu, P. S., Padi, S. S. V., & Goyal, R. (2007) · PubMed · Cited by 73
Active DNA demethylation in post-mitotic neurons: A reason for optimism
Gavin, D. P., Chase, K. A., & Sharma, R. P. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.036 · Cited by 72
MicroRNAs and the Regulation of Tau Metabolism
Hébert, S. S., Sergeant, N., & Buée, L. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/406561 · Cited by 72
Developmental Regulation of MicroRNA Expression in Schwann Cells
Gokey, N. G., Srinivasan, R., Lopez‐Anido, C., Krueger, C., & Svaren, J. P. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06270-11 · Cited by 72
Mastroeni, D., Chouliaras, L., Grover, A., Liang, W. S., Hauns, K., Rogers, J., & Coleman, P. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053349 · Cited by 72
Self-citationInducible PC12 cell model of Huntington’s disease shows toxicity and decreased histone acetylation
Igarashi, S., Morita, H., Bennett, K. M., Tanaka, Y., Engelender, S., Peters, M. F., Cooper, J. K., Wood, J. D., Sawa, A., & Ross, C. A. (2003) · Neuroreport · doi:10.1097/00001756-200303240-00007 · Cited by 72
Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease
Fukutani, Y., Cairns, N. J., Rossor, M. N., & Lantos, P. L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12875-5 · Cited by 71
Müerköster, S. S., Werbing, V., Koch, D., Sipos, B., Ammerpohl, O., Kalthoff, H., Tsao, M., Fölsch, U. R., & Schäfer, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23703 · Cited by 71
Kelly‐Sell, M. J., Kim, Y. H., Straus, S., Benoit, B. M., Harrison, C., Sutherland, K., Armstrong, R. J., Weng, W., Showe, L. C., Wysocka, M., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23112 · Cited by 70
Choi, Y.-S., Jeong, J. H., Min, H., Jung, H.-J., Hwang, D., Lee, S., & Pak, Y. K. (2011) · Molecular BioSystems · doi:10.1039/c0mb00277a · Cited by 70
New Neurons in Aging Brains: Molecular Control by Small Non-Coding RNAs
Schouten, M., Buijink, M. R., Lucassen, P. J., & Fitzsimons, C. P. (2012) · Frontiers in Neuroscience · doi:10.3389/fnins.2012.00025 · Cited by 70
Tohgi, H., Utsugisawa, K., Nagane, Y., Yoshimura, M., Ukitsu, M., & Genda, Y. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00731-4 · Cited by 70
Emerging neurotoxic mechanisms in environmental factors-induced neurodegeneration
Kanthasamy, A. G., Jin, H., Anantharam, V., Sondarva, G. V., Rangasamy, V., Rana, A., & Kanthasamy, A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.011 · Cited by 70
The therapeutic role of creatine in Huntington's disease
Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.008 · Cited by 69
Antibodies specific for N6‐methyladenosine react with intact snRNPs U2 and U4/U6
Bringmann, P., & Lührmann, R. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81512-0 · Cited by 69
van de Berg, W. D. J., Hepp, D. H., Dijkstra, A. A., Rozemüller, A. J. M., Berendse, H. W., & Foncke, E. M. J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70011-6 · Cited by 69
Lee, S., Lemere, C. A., Frost, J. L., & Shea, T. B. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111025 · Cited by 68
Self-citationChan, M. F., van Amerongen, R., Nijjar, T., Cuppen, E. P. J. G., Jones, P. A., & Laird, P. W. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7587-7600.2001 · Cited by 68
Shimba, S., Bokar, J. A., ROTTMAN, F. M., & Reddy, R. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.13.2421 · Cited by 68
Environmental exposure and mitochondrial epigenetics: study design and analytical challenges
Byun, H.-M., & Baccarelli, A. A. (2014) · Human Genetics · doi:10.1007/s00439-013-1417-x · Cited by 68
RNA as the substrate for epigenome‐environment interactions
Mattick, J. S. (2010) · BioEssays · doi:10.1002/bies.201000028 · Cited by 67
Inactive DNMT3B Splice Variants Modulate De Novo DNA Methylation
Gordon, C. A., Hartono, S. R., & Chedin, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069486 · Cited by 67
Thomas, B., Matson, S. A., Chopra, V., Sun, L., Sharma, S., Hersch, S. M., Rosas, H. D., Scherzer, C. R., Ferrante, R. J., & Matson, W. R. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.01.035 · Cited by 67
de Boni, L., Tierling, S., Roeber, S., Walter, J., Giese, A., & Kretzschmar, H. A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8163-9 · Cited by 67
New Criteria for Alzheimer Disease and Mild Cognitive Impairment
Budson, A. E., & Solomon, P. R. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31826a998d · Cited by 65
Voutsinas, G. E., Stavrou, E. F., Karousos, G., Dasoula, A., Papachatzopoulou, A., Syrrou, M., Verkerk, A. J. M. H., van der Spek, P. J., Patrinos, G. P., Stöger, R. J., et al. (2010) · Human Mutation · doi:10.1002/humu.21248 · Cited by 64
Depolarization induces downregulation of DNMT1 and DNMT3 in primary cortical cultures
Sharma, R. P., Tun, N., & Grayson, D. R. (2008) · Epigenetics · doi:10.4161/epi.3.2.6103 · Cited by 63
Pharmacogenomics and therapeutic prospects in Alzheimer’s disease
Cacabelos, R. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.12.1967 · Cited by 63
Nuutinen, T., Suuronen, T., Kauppinen, A., & Salminen, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.041 · Cited by 63
Molecular insights into Parkinson's disease
Thomas, B., & Beal, M. F. (2011) · F1000 Medicine Reports · doi:10.3410/m3-7 · Cited by 62
van den Hove, D., Chouliaras, L., & Rutten, B. P. F. (2012) · Current Alzheimer Research · doi:10.2174/156720512800618008 · Cited by 62
Self-citationModified nucleotides in T1 RNase oligonucleotides of 18S ribosomal RNA of the Novikoff hepatoma
Choi, Y. C., & Busch, H. (1978) · Biochemistry · doi:10.1021/bi00606a015 · Cited by 62
Methylation of P16, P21, P27, RB1 and P53 genes in odontogenic keratocysts
Moreira, P. R., Guimarães, M. M., Guimarães, A. L. S., Diniz, M. G., Gomes, C. C., Brito, J. A. R., & Gomez, R. S. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00718.x · Cited by 62
Pan, K., Chen, Y., Roth, M. M., Wang, W., Wang, S., Yee, A. S., & Zhang, X. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00637-12 · Cited by 61
Müller, G. B., & Olsson, L. (2006) · Harvard University Press eBooks · doi:10.2307/j.ctv228vqrq.21 · Cited by 59
APOBEC3 proteins and reverse transcription
Aguiar, R. S., & Peterlin, B. M. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.022 · Cited by 58
Prado, L., Lombó, F., Braña, A. F., Méndez, C., Rohr, J., & Salas, J. A. (1999) · Molecular and General Genetics MGG · doi:10.1007/s004380050960 · Cited by 58
High-Capacity Adenoviral Vector-Mediated Reduction of Huntingtin Aggregate Load In Vitro and In Vivo
Huang, B., Schiefer, J., Saß, C., Landwehrmeyer, G. B., Kosinski, C. M., & Kochanek, S. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.160 · Cited by 57
Clusterin is epigenetically regulated in prostate cancer
Rauhala, H. E., Porkka, K. P., Saramäki, O. R., Tammela, T. L. J., & Visakorpi, T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23658 · Cited by 57
NMR-Based Metabonomic Investigations into the Metabolic Profile of the Senescence-Accelerated Mouse
Jiang, N., Yan, X., Zhou, W., Zhang, Q., Chen, H., Zhang, Y., & Zhang, X. (2008) · Journal of Proteome Research · doi:10.1021/pr800439b · Cited by 56
Tian, F., Marini, A. M., & Lipsky, R. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05175.x · Cited by 55
Zhu, M., Li, W., & Lü, C. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12217 · Cited by 55
Cacciapuoti, F. (2012) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-012-0856-x · Cited by 55
Duclot, F., Meffre, J., Jacquet, C., Gongora, C., & Maurice, T. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.055 · Cited by 55
Werner, A. (2005) · RNA Biology · doi:10.4161/rna.2.2.1852 · Cited by 55
Evaluation of the poly(ADP‐ribose) polymerase‐1 gene variants in Alzheimer's disease
Liu, H., Lin, W., Wu, B., Liu, S. R., Wang, W., Tsai, C., Lee, C., & Tsai, F. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20379 · Cited by 54
Striatal specificity of gene expression dysregulation in Huntington's disease
Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21046 · Cited by 53
Chouliaras, L., van den Hove, D., Kenis, G., van Draanen, M., Hof, P. R., van Os, J., Steinbusch, H. W. M., Schmitz, C., & Rutten, B. P. F. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310080009 · Cited by 53
Self-citationHigh Expression of Apolipoprotein E mRNA in the Brains with Sporadic Alzheimer’s Disease
Yamagata, K., Urakami, K., Ikeda, K., Ji, Y., Adachi, Y., Arai, H., Sasaki, H., Sato, K., & Nakashima, K. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051236 · Cited by 53
Mutational analysis of the damage-recognition and catalytic mechanism of human SMUG1 DNA glycosylase
Matsubara, M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh859 · Cited by 52
TET proteins: on the frenetic hunt for new cytosine modifications
Delatte, B., & Fuks, F. (2013) · Briefings in Functional Genomics · doi:10.1093/bfgp/elt010 · Cited by 51
Chakrabarti, S., Bhattacharyya, D., & Dasgupta, D. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:2 · Cited by 51
Lee, J.-H., Hwang, Y. J., Shin, J.-Y., Lee, W., Wie, J., Kim, K. Y., Lee, M. Y., Hwang, D., Ratan, R. R., Pae, A. N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1103-z · Cited by 50
Akram, A., Schmeidler, J., Katsel, P., Hof, P. R., & Haroutunian, V. (2010) · Brain Research · doi:10.1016/j.brainres.2010.01.006 · Cited by 50
Self-citationEpigenetics-Based Therapeutics for Neurodegenerative Disorders
Xu, Z., Li, H., & Jin, P. (2012) · Current Geriatrics Reports · doi:10.1007/s13670-012-0027-0 · Cited by 49
Emerging roles of epigenetic mechanisms in Parkinson’s disease
Habibi, E., Masoudi‐Nejad, A., Abdolmaleky, H. M., & Haggarty, S. J. (2011) · Functional & Integrative Genomics · doi:10.1007/s10142-011-0246-z · Cited by 48
Age-related gene-specific changes of A-to-I mRNA editing in the human brain
Nicholas, A., de Magalhaes, J. P., Kraytsberg, Y., Richfield, E. K., Levanon, E. Y., & Khrapko, K. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.06.001 · Cited by 48
Ishimaru, N., Fukuchi, M., Hirai, A., Chiba, Y., Tamura, T., Takahashi, N., Tabuchi, A., Tsuda, M., & Shiraishi, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.139 · Cited by 47
Regulation of transposable elements in maize
Lisch, D. R. (2012) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2012.07.001 · Cited by 46
Biological significance of protein modifications in aging and calorie restriction
Nakamura, A., Kawakami, K., Kametani, F., Nakamoto, H., & Goto, S. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05374.x · Cited by 46
Pharmacogenetic Basis for Therapeutic Optimization in Alzheimer’s Disease
Cacabelos, R. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256262 · Cited by 45
Epigenetic control on cell fate choice in neural stem cells
Hu, X.-L., Wang, Y., & Shen, Q. (2012) · Protein & Cell · doi:10.1007/s13238-012-2916-6 · Cited by 45
The Mitochondrial Epigenome: a Role in Alzheimer’s Disease?
Devall, M. A. M., Mill, J. S., & Lunnon, K. (2014) · Epigenomics · doi:10.2217/epi.14.50 · Cited by 45
Lee, J.-H., Hagerty, S. W., Cormier, K., Kim, J., Kung, A. L., Ferrante, R. J., & Ryu, H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn067 · Cited by 45
Epigenetic Regulation of Mammalian Genomes by Transposable Elements
Huda, A., & Jordan, I. K. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05007.x · Cited by 45
Brohede, J., Rinde, M., Winblad, B. G., & Graff, C. (2010) · Journal of Neurogenetics · doi:10.3109/01677063.2010.503978 · Cited by 45
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease (Erratum)
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/356862 · Cited by 44
Self-citationA ternary complex consisting of AICD, FE65, and TIP60 down-regulates Stathmin1
Müller, T., Schrötter, A., Looße, C., Pfeiffer, K., Theiß, C., Kauth, M., Meyer, H. E., & Marcus, K. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.07.017 · Cited by 44
Mitochondrial DNA: a blind spot in neuroepigenetics
Manev, H., Dzitoyeva, S., & Chen, H. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2011-0058 · Cited by 44
Morgan, A. R., Hamilton, G., Turic, D., Jehu, L., Harold, D. H., Abraham, R., Hollingworth, P., Moskvina, V., Brayne, C., Rubinsztein, D. C., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30670 · Cited by 44
Dysfunction of Wild-Type Huntingtin in Huntington disease
Cattaneo, E. F. (2003) · Physiology · doi:10.1152/nips.01410.2002 · Cited by 44
Alterations in Tau Protein Metabolism during Normal Aging
Mukaetova-Ladinska, E., Harrington, C. R., Roth, M., & Wischik, C. M. (1996) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106861 · Cited by 43
Toward an integrated genetic and epigenetic approach to Alzheimer's disease
Mill, J. S. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.021 · Cited by 43
Treatment of Paget's Disease of Bone with Mithramycin
Ryan, W. G. (1977) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-197709000-00012 · Cited by 43
Liu, R., Lei, J. X., Luo, C., Lan, X., Chi, L., Deng, P., Lei, S., Ghribi, O., & Liu, Q. Y. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.007 · Cited by 42
Deciphering the biosynthetic origin of the aglycone of the aureolic acid group of anti-tumor agents
Blanco, G., Fu, H., Méndez, C., Khosla, C., & Salas, J. A. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90262-8 · Cited by 42
Loss of caspase-1 gene expression in human gastric carcinomas and cell lines
Jee, C. D., Lee, H. J., Bae, S., Han, Y., Lee, Y. J., Rho, M., & Kim, W. H. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.5.1265 · Cited by 42
Alzheimer's Disease Modeling: Ups, Downs, and Perspectives for Human Induced Pluripotent Stem Cells
Wojda, U., & Kuźnicki, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121984 · Cited by 40
Using non-coding small RNAs to develop therapies for Huntington's disease
Zhang, Y., & Friedlander, R. M. (2011) · Gene Therapy · doi:10.1038/gt.2011.170 · Cited by 39
Xiong, M., Zhang, T., Zhang, L., Lu, S.-D., Huang, Y.-L., & Sun, F. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.007 · Cited by 39
Kirilyuk, A., Shimoji, M., Catania, J., Sahu, G., Pattabiraman, N., Giordano, A., Albanese, C., Mocchetti, I., Toretsky, J. A., Uversky, V. N., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048243 · Cited by 38
Whittemore, S. R., Sanon, H. R., & Wood, P. M. (1993) · International Journal of Developmental Neuroscience · doi:10.1016/0736-5748(93)90064-k · Cited by 37
Epigenetic changes and non-coding expanded repeats
Nakamori, M., & Thornton, C. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.004 · Cited by 36
Induction of clusterin/apoJ expression by histone deacetylase inhibitors in neural cells
Nuutinen, T., Suuronen, T., Kyrylenko, S., Huuskonen, J., & Salminen, A. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.07.007 · Cited by 36
Pasinetti, G. M., Ho, L., Dooley, C., Abbi, B., & Lange, G. (2012) · Europe PMC (PubMed Central) · Cited by 36
Leng, Y., Marinova, Z., Reis-Fernandes, M. A., Nau, H., & Chuang, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.013 · Cited by 36
Fukuda, T. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00402.x · Cited by 35
Study of Methylation Levels of Parkin Gene Promoter in Parkinson's Disease Patients
Cai, M., Tian, J., Zhao, G., Luo, W. F., & Zhang, B. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2011.580866 · Cited by 35
Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron
Yoon, S. Y., Choi, H., Choi, J. E., Sul, C. A., Choi, J. M., & Kim, D. H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.060 · Cited by 35
dTip60 HAT Activity Controls Synaptic Bouton Expansion at the Drosophila Neuromuscular Junction
Sarthi, J. B., & Elefant, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026202 · Cited by 34
Toxins and Parkinson's disease: MPTP parkinsonism in humans and animals.
Kopin, I. J. (1987) · PubMed · Cited by 34
Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
Kh, M. I., & Kassem, L. A. A. (2011) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2011.257.272 · Cited by 33
Xu, T., Li, L., Huang, C., Li, X., Peng, Y., & Li, . (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.855201 · Cited by 32
Suicidal function of DNA methylation in age-related genome disintegration
Mazin, A. L. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.005 · Cited by 32
Ebbel, E. N., Leymarie, N., Schiavo, S., Sharma, S., Gevorkian, S., Hersch, S. M., Matson, W. R., & Costello, C. E. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.01.010 · Cited by 32
Amyloid precursor protein expression is induced by tumor necrosis factor α in 3T3‐L1 adipocytes
Sommer, G., Kralisch, S., Lipfert, J., Weise, S., Krause, K., Jeßnitzer, B., Lössner, U., Blüher, M., Stümvoll, M., & Faßhauer, M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22382 · Cited by 32
Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease
Chouliaras, L., Sierksma, A. S. R., Kenis, G., Prickaerts, J., Lemmens, M. A. M., Brasnjevic, I., van Donkelaar, E. L., Martínez‐Martínez, P., Losen, M. H., Baets, M. H. D., et al. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/859101 · Cited by 30
Self-citationPiña, B., Martı́nez, P., & Suau, P. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14099.x · Cited by 30
Pathogenesis and Management of Cancer-Associated Hypercalcaemia
Ralston, S. H. (1991) · Springer eBooks · doi:10.1007/978-1-4471-3254-7_8 · Cited by 30
RNA Interference from Biology to Therapeutics
Howard, K. A. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3 · Cited by 29
Mithramycin Therapy in Testicular Cancer
Kennedy, B. J. (1972) · The Journal of Urology · doi:10.1016/s0022-5347(17)61046-2 · Cited by 29
Protein abnormalities in Huntington's chorea
Iqbal, K., Tellez-Nagel, I., & Grunke-Iqbal, I. (1974) · Brain Research · doi:10.1016/0006-8993(74)90527-7 · Cited by 28
Most human Alu and Murine B1 repeats are unique
Umylny, B., Presting, G. G., Efird, J. T., Klimovitsky, B. I., & Ward, W. S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21278 · Cited by 27
Tanaka, T., & Weisblum, B. (1975) · Journal of Bacteriology · doi:10.1128/jb.123.2.771-774.1975 · Cited by 26
Immunospecific retention of oligonucleotides possessing N6-methyladenosine and 7-methylguanosine.
Munns, T. W., Sims, H. F., & Liszewski, M. K. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40477-7 · Cited by 26
Thakur, M. K., & Kanungo, M. S. (1981) · Experimental Gerontology · doi:10.1016/0531-5565(81)90052-8 · Cited by 26
Yu, S., Zhang, J., Zhao, C., Zhang, H., & Xu, Q. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000035484.64499.ac · Cited by 26
Epigenetic regulation of estrogen receptor beta expression in the rat cortex during aging
Westberry, J. M., Trout, A. L., & Wilson, M. E. (2011) · Neuroreport · doi:10.1097/wnr.0b013e328346e1cf · Cited by 24
MicroRNAs and Molecular Mechanisms of Neurodegeneration
Bicchi, I., Morena, F., Montesano, S., Polidoro, M., & Martino, S. (2013) · Genes · doi:10.3390/genes4020244 · Cited by 23
Induced pluripotent stem cells and promises of neuroregenerative medicine
Verma, A. K., & Verma, N. (2011) · Neurology India · doi:10.4103/0028-3886.84337 · Cited by 23
Tian, C., Liu, Q., Ma, K., Wang, Y., Chen, Q., Ambroz, R., Klinkebiel, D. L., Li, Y., Huang, Y., Ding, J., et al. (2013) · Scientific Reports · doi:10.1038/srep01345 · Cited by 22
Guffanti, A., Simchovitz, A., & Soreq, H. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00089 · Cited by 22
So, K., Tamura, G., Honda, T., Homma, N., Endoh, M., Togawa, N., Nishizuka, S., & Motoyama, T. (2006) · Pathology International · doi:10.1111/j.1440-1827.2006.02010.x · Cited by 21
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Caesar, I., & Gandy, S. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-36 · Cited by 20
Kudriashova, I. B., Kirnos, M. D., & Bf, V. (1976) · PubMed · Cited by 19
Huang, H., Lin, S., Chen, W.-F., Li, K.-W., Kuo, J., & Wang, M.-J. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.09.010 · Cited by 19
Non-coding RNA detection methods combined to improve usability, reproducibility and precision
Raasch, P., Schmitz, U., Patenge, N., Vera, J., Kreikemeyer, B., & Olaf Wolkenhauer, A. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-491 · Cited by 19
Sharma, R. P. (2012) · Epigenomics · doi:10.2217/epi.12.46 · Cited by 16
Region-specific neuron and synapse loss in the hippocampus of APPSL/PS1 knock-in mice
Brasnjevic, I., Lardenoije, R., Schmitz, C., van der Kolk, N. M., Dickstein, D. L., Takahashi, H., Hof, P. R., Steinbusch, H. W. M., & Rutten, B. P. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0111-8 · Cited by 16
Self-citationP3‐260: Epigenetic modification in a monozygotic twin with Alzheimer's disease
Ryu, H., Barrup, M., Kowall, N. W., & McKee, A. C. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1828 · Cited by 16
A-to-I RNA editing does not change with age in the healthy male rat brain
Holmes, A. P., Wood, S. H., Merry, B. J., & de Magalhães, J. P. (2013) · Biogerontology · doi:10.1007/s10522-013-9433-8 · Cited by 16
P2‐146: Epigenetic changes related to beta‐amyloid‐implications for Alzheimer's disease
Lithner, C. U., Hernandez, C. M., Nordberg, A. K., & Sweatt, J. D. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.457 · Cited by 16
Caloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in mice
Rutten, B. P. F., Brasnjevic, I., Steinbusch, H. W. M., & Schmitz, C. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.08.002 · Cited by 15
Self-citationTschöp, K., & Engeland, K. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06045.x · Cited by 15
Altered DNA methylation and RNA splicing could be key mechanisms in Huntington disease
Wood, H. B. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.23 · Cited by 14
DNA Methylation and Alzheimer’s Disease
van Groen, T. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0639-7_17 · Cited by 10
RNA as the substrate for epigenome‐environment interactions
Mattick, J. S. (2010) · BioEssays · doi:10.1002/bies.201090026 · Cited by 10
RNAi Therapeutic Delivery by Exosomes
Lakhal, S., Andaloussi, S. E., O’Loughlin, A. J., Li, J., & Wood, M. M. J. (2012) · Advances in delivery science and technology · doi:10.1007/978-1-4614-4744-3_9 · Cited by 8
Research works printed but not linked: 2
- Alarcón, 2004, Chromatin acetylation, memory, and LTP are impaired in CBP+/− mice: a model for the cognitive deficit in Rubinstein–Taybi syndrome and its amelioration, Neuron, 42, 947, 10.1016/j.neuron.2004.05.021 · DOI · Paper page
- Lovestone, 1997, The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes, Neuroscience, 78, 309
Cited by
Sorted by citations
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967
Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s200490 · Cited by 1,308
Predicting Age Using Neuroimaging: Innovative Brain Ageing Biomarkers
Cole, J. H., & Franke, K. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.10.001 · Cited by 939
β-Hydroxybutyrate: A Signaling Metabolite
Newman, J. C., & Verdin, E. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064916 · Cited by 872
“The broader role of epigenetics in cognition and neurodegenerative disease has been reviewed (67, 68, 100).”
Šimić, G., Leko, M. B., Wray, S., Harrington, C. R., Delalle, I., Milošević, N. J., Bažadona, D., Buée, L., de Silva, R., Giovanni, G. D., et al. (2016) · Biomolecules · doi:10.3390/biom6010006 · Cited by 730
Self-citation
Metadata
- Authors
- Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., & Rutten, B. P. F.
- Affiliations
- Maastricht University (NL)
- University of Lausanne (CH)
- Banner Sun Health Research Institute (US)
- Brigham and Women's Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Rutten, Bart P.F.
- ORCID
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 131
- Pages
- 21-64
- ISSN
- 0301-0082 (ISSN-L)
- PMC
- PMC6477921
- OpenAlex
- W648684004
- Cited by
- 381
- References
- 770
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 28 · 2023: 28 · 2022: 32 · 2021: 47 · 2020: 30 · 2019: 42 · 2018: 39 · 2017: 43 · 2016: 38 · 2015: 11
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Internationale Stichting Alzheimer Onderzoek (07551, 11532, 09552, 13515)
- Netherlands Organization for Scientific Research (916.11.086)
- National Institutes of Health (P50 AG005138)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- epigenetics, aging, neurodegeneration, DNA methylation, DNA demethylation, chromatin remodeling, non-coding RNA, Alzheimer's disease, Parkinson's disease, Huntington's disease, epigenetic therapy, gene expression regulation, histone modifications
- MeSH terms
- Aging, Animals, Humans, DNA Methylation, Neurodegenerative Diseases, Genetic Predisposition to Disease, RNA, Untranslated, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review